Form D · Biotechnology
AptaCo, Inc.
Wilmington, DE · CIK 0001647844
Offering snapshot reported Jul 15, 2015 · SEC filing
- Reported sold
- $200K Offering amount: $200K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 15, 2015 | Initial | $200,000 | No comparison | 1 | SEC filing |
| Jul 13, 2015 | Initial | $8 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-243809
Source: Form D, filed Jul 15, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jason Smith | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1105 North Market Street Suite 1800
Wilmington, DE, 19801
Wilmington, DE, 19801